Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/24 20:09 | 3/8/24 | XENE | Health | Drug | Pharmaceutical Preparations | Garofalo Elizabeth A. | A1 | D | 1 | S.d | -96 | 45.69 | 0 | -2 | -100 | 0 | D | |||||||||||||||
3/8/24 17:31 | 3/7/24 | XENE | Health | Drug | Pharmaceutical Preparations | Robin Sherrington | A1 | O | EVP,Stra | 1 | S.d | -330 | 46.28 | 0 | -7 | 8 | D | |||||||||||||||
3/8/24 17:28 | 3/7/24 | XENE | Health | Drug | Pharmaceutical Preparations | Gannon Steven | A1 | D | 1 | S | -602 | 46.28 | 0 | -13 | 2 | D | ||||||||||||||||
12/15/23 21:50 | 12/14/23 | XENE | Health | Drug | Pharmaceutical Preparations | Patou Gary | A1 | D | 2 | S.d | -1,071 | 40.30 | 0 | -27 | 28 | I | ||||||||||||||||
8/24/23 16:33 | 8/24/23 | XENE | Health | Drug | Pharmaceutical Preparations | Svoronos Dawn | A1 | D | 1 | S | -968 | 38.70 | 0 | -25 | 25 | D | ||||||||||||||||
6/1/23 19:25 | 3/7/23 | XENE | Health | Drug | Pharmaceutical Preparations | Pimstone Simon N. | Z4 | D | 2 | S.dm | -5,816 | 38.65 | 0 | -150 | 55 | D | ||||||||||||||||
5/26/23 19:10 | 5/24/23 | XENE | Health | Drug | Pharmaceutical Preparations | Mortimer Ian | Z4 | DO | P,CEO | 1 | S.d | -1,311 | 41.41 | 0 | -32 | 46 | D | |||||||||||||||
3/24/23 19:18 | 3/24/23 | XENE | Health | Drug | Pharmaceutical Preparations | Kenney Christopher John | A1 | O | Chief Me | 1 | S | -25 | 35.01 | 0 | -1 | -100 | 0 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |